Geode Capital Management’s Cellebrite CLBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.26M Buy
428,874
+33,749
+9% +$446K ﹤0.01% 2796
2026
Q1
$5.44M Buy
395,125
+23,386
+6% +$352K ﹤0.01% 2694
2025
Q4
$6.7M Buy
371,739
+31,855
+9% +$572K ﹤0.01% 2613
2025
Q3
$6.3M Buy
339,884
+25,444
+8% +$400K ﹤0.01% 2665
2025
Q2
$5.03M Buy
314,440
+43,898
+16% +$783K ﹤0.01% 2726
2025
Q1
$5.26M Buy
270,542
+24,280
+10% +$511K ﹤0.01% 2626
2024
Q4
$5.43M Buy
246,262
+6,994
+3% +$135K ﹤0.01% 2707
2024
Q3
$4.03M Sell
239,268
-3,029
-1% -$44.9K ﹤0.01% 2875
2024
Q2
$2.9M Buy
242,297
+87,544
+57% +$978K ﹤0.01% 2999
2024
Q1
$1.71M Buy
154,753
+23,255
+18% +$237K ﹤0.01% 3174
2023
Q4
$1.14M Buy
131,498
+480
+0.4% +$3.73K ﹤0.01% 3307
2023
Q3
$1M Sell
131,018
-744
-0.6% -$5.58K ﹤0.01% 3318
2023
Q2
$949K Buy
131,762
+11,772
+10% +$68.6K ﹤0.01% 3382
2023
Q1
$731K Buy
119,990
+2,115
+2% +$11.5K ﹤0.01% 3496
2022
Q4
$513K Hold
117,875
﹤0.01% 3649
2022
Q3
$462K Buy
117,875
+8,446
+8% +$42.3K ﹤0.01% 3762
2022
Q2
$558K Sell
109,429
-1,158
-1% -$6.02K ﹤0.01% 3704
2022
Q1
$707K Buy
110,587
+6,459
+6% +$42.8K ﹤0.01% 3769
2021
Q4
$835K Buy
104,128
+30,486
+41% +$287K ﹤0.01% 3792
2021
Q3
$681K Buy
+73,642
New +$770K ﹤0.01% 3879

Other funds holding CLBT

Geode Capital Management's CLBT Position: Q2 2026 in Review

Geode Capital Management increased its Cellebrite (CLBT) stake by 8.5% in Q2 2026, buying an estimated $446K and bringing the position to 428,874 shares worth $6.26M. The position accounts for ﹤0.01% of the portfolio, ranked #2796.

Geode Capital Management first reported a position in CLBT in Q3 2021 and has held it in 20 quarters since. The position peaked at $6.7M in Q4 2025. 201 funds tracked by Wall St. Rank hold CLBT as of Q2 2026.

  • Geode Capital Management held 428,874 shares of Cellebrite worth $6.26M as of Q2 2026.
  • Geode Capital Management bought 33,749 Cellebrite shares in Q2 2026, an estimated $446K.
  • Cellebrite made up ﹤0.01% of Geode Capital Management's portfolio in Q2 2026, its #2796 holding.
  • Geode Capital Management first reported a position in Cellebrite in Q3 2021 and has held it in 20 quarters since.
  • Geode Capital Management's Cellebrite position peaked at $6.7M in Q4 2025.
  • 201 funds tracked by Wall St. Rank held Cellebrite as of Q2 2026.

Based on Geode Capital Management's 13F filing for Q2 2026, filed 12 Aug 2026.